Anbio Biotechnology (NNNN) - Latest Market Data

Price & Market Data

Price: $25.80

Daily Change: +$0.45 / 1.74%

Daily Range: $22.89 - $26.50

Market Cap: $1,132,392,960

Daily Volume: 23,367

Performance Metrics

1 Week: -11.64%

1 Month: -9.60%

3 Months: 3.61%

6 Months: 50.88%

1 Year: 278.3%

YTD: -14.20%

About Anbio Biotechnology (NNNN)

A snapshot of Anbio Biotechnology (NNNN)'s current market standing: priced at 25.80, with a daily adjustment of +$0.45 / 1.74%. Market cap at 1,132,392,960. Performance over the last 6 months (50.88%) and YTD are particularly insightful.

Company Details

Employees: 27

Sector: Health technology

Industry: Medical specialties

Country: Germany

Details

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Selected stocks

CRH PLC (CRH)

ServiceTitan, Inc. (TTAN)

reAlpha Tech Corp. (AIRE)

John Wiley & Sons, Inc. (WLYB)